MARCELLUSI, A.; BINI, C.; FIORAVANTI, L.; RIPOLI, S.; MORELLI, P. Cost-effectiveness of Brentuximab Vedotin plus chemotherapy as frontline treatment of systemic anaplastic large cell lymphoma in Italy. Global and Regional Health Technology Assessment, [S. l.], v. 12, n. 1, p. 106–117, 2025. DOI: 10.33393/grhta.2025.3306. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/3306. Acesso em: 5 may. 2025.